Abstract

Alzheimer's disease (AD) presents a complex clinical challenge, necessitating exploration of innovative therapeutic approaches. This paper investigates the integration of a medicinal Cannabis MCT oil protocol, featuring specific THC and CBD ratios, within the care plans of three individuals diagnosed with AD. Drawing upon existing literature and detailed case studies, we evaluate the protocol's impact on symptom progression, quality of life, and caregiver burden. Our analysis suggests promising therapeutic benefits of medicinal Cannabis in mitigating symptoms associated with AD, underscoring the importance of further research in this evolving field. Keywords: alzheimer's disease, medicinal cannabis, THC, CBD, symptom management, caregiver burden, neuroprotection, anti-inflammatory properties

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.